You are here
Home ›Services
Medical Subsidies to Patients
- Automated Peritoneal Dialysis Programme
- Travelling Allowance for Haemodialysis Treatment
- Rituximab (or its biosimilar) Treatment Subsidy
- Obinutuzumab Treatment Subsidy
- Anti-CD38 Monoclonal Antibody - Daratumumab Treatment Subsidy
- Sodium Zirconium Cyclosilicate (Lokelma) Treatment Subsidy
- C5 Inhibitors - Eculizumab / Ravulizumab Treatment Subsidy
Medical Research & Training
Activities & Non-Medical Subsidies for Patients & Families
| Attachment | Size |
|---|---|
| 254.69 KB |
- Home
- About Us
- Kidney Health
- Services
- Automated Peritoneal Dialysis Programme
- Travelling Allowance for Haemodialysis Treatment
- Subsidy for Rituximab/ Biosimilar to Rituximab
- Subsidy for Obinutuzumab
- Subsidy for Anti-CD38 Monoclonal Antibody - Daratumumab
- Subsidy for Sodium Zirconium Cyclosilicate (Lokelma)
- The IPNA Prof. Chiu Fellowship Fund for Paediatric Nephrology
- Support for Research & Training
- Patient and Family Activities
- Sharings
- Support Us
- Contact
- Introductory information and Photos of Activities
- Online Donation Form
- Related Links

